Attention: This platform is in beta mode. Expect some changes and adjustments.

AI Market Mood: Stock Dashboard

NKTX


Fundamental

Company: Nkarta Inc
Sector: Healthcare
Industry: Biotechnology
Country: USA
Exchange: NASD
Index: RUT
P/E: -
EPS (ttm): -1.39
Insider Own: 20.11%
Shs Outstand: 71.02M
Perf Week: -2.44%
Market Cap: 142.06M
Forward P/E: -
EPS next Y: -1.23
Insider Trans: -0.22%
Shs Float: 56.74M
Perf Month: -8.26%
Enterprise Value: -63.64M
PEG: -
EPS next Q: -0.31
Inst Own: 73.09%
Short Float: 11.52%
Perf Quarter: 2.04%
Income: -102.61M
P/S: -
EPS this Y: 17.90%
Inst Trans: -0.26%
Short Ratio: 8.86
Perf Half Y: 2.04%
Sales: 0.00M
P/B: 0.42
EPS next Y Percentage: 5.99%
ROA: -21.39%
Short Interest: 6.54M
Perf YTD: 8.11%
Book/sh: 4.76
P/C: 0.50
EPS next 5Y: 6.74%
ROE: -26.69%
52W High: 2.74 -27.01%
Perf Year: -1.48%
Cash/sh: 3.97
P/FCF: -
EPS past 3/5Y: 15.10% -19.86%
ROIC: -25.14%
52W Low: 1.31 52.67%
Perf 3Y: -62.19%
Dividend Est.: -
EV/EBITDA: -
Sales past 3/5Y: - -
Gross Margin: -
Volatility W: 6.35%
Volatility M: 6.51%
Perf 5Y: -96.15%
Dividend TTM: -
EV/Sales: -
EPS Y/Y TTM: 25.84%
Oper. Margin: -
ATR (14): 0.13
Perf 10Y: -
Dividend Ex-Date: -
Quick Ratio: 15.23
Sales Y/Y TTM: -
Profit Margin: -
RSI (14): 44.26
Recom: 1.29
Dividend Gr. 3/5Y: - -
Current Ratio: 15.23
EPS Q/Q: 23.85%
SMA20: -8.47%
Beta: 0.53
Target Price: 11.80
Payout: -
Debt/Eq: 0.23
Sales Q/Q: -
SMA50: 0.02%
Rel Volume: 0.67
Prev Close: 2.00
Employees: 157
LT Debt/Eq: 0.21
Earnings: Nov 10 AMC
SMA200: -0.11%
Avg Volume: 738.07K
Price: 2.00
IPO: Jul 10, 2020
Option/Short: Yes / Yes
EPS/Sales Surpr.: 4.89% -
Trades:
Volume: 500,947
Change: 0.00%

Technical:


Latest News:

Cullinan stock rises on Amgen's Blincyto data (NASDAQ:CGEM) | Seeking Alpha very bullish
CGEM AMGN ADCT ALLO AZN AUTL BMY IPSC GILD MOR NKTX NVS

Summary: Cullinan Therapeutics (CGEM) stock surged ~58% last week after positive data for CD19-targeting therapy similar to competitor Amgen's Blincyto, showing efficacy against autoimmune diseases like rheumatoid arthritis and systemic sclerosis.

Full article
2024-04-27T19:44:12Z